About this trial
This trial is to compare the use of Chemoradiotherapy with or without Pembrolizumab for the treatment of High-risk Locally Advanced Cervical Cancer
For women over 18 with Stage IB2-IIB and Stage III-IV A cervical cancer.
Where’s this trial being run?
Cork University Hospital and St James’s Hospital
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.Print this page
For more detailed informationClick Here
|Name:||KEYNOTE-A18 / ENGOT-cx11|
A Randomized, Phase 3, Double-Blind Study of Chemoradiotherapy With or
|Principal Investigator:||Dr Dearbhaile Collins|
Merck Sharp & Dohme
Global: 12 May 2020
Ireland: Feb 2021
|Global Recruitment Target:||980|
|Ireland Recruitment Target:||N/A|